Skip to main content
Ethan Weinberg, MD, Gastroenterology, Philadelphia, PA

EthanMichaelWeinbergMD

Gastroenterology Philadelphia, PA

Hepatology & Liver Transplantation

Assistant Professor of Clinical Medicine

Dr. Weinberg is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Weinberg's full profile

Already have an account?

  • Office

    3400 Civic Center Blvd
    Philadelphia, PA 19104
    Phone+1 800-789-7366
    Fax+1 215-349-5915

Education & Training

  • Rockefeller University
    Rockefeller UniversityMS, Clinical Investigation, 2016
  • New York Presbyterian Hospital (Cornell Campus)
    New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 2009 - 2012
  • University of Maryland School of Medicine
    University of Maryland School of MedicineClass of 2009
  • University of Maryland
    University of MarylandMD, 2009
  • Princeton University
    Princeton UniversityAB, 2003

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2016 - 2024
  • NY State Medical License
    NY State Medical License 2011 - 2016
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Gastroenterology

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024
    PharmaIN Unveils Interim Phase 1b Clinical Data on the Activity and Safety of PHIN-214 in Decompensated Liver Cirrhosis at AASLD - the Liver Meeting® 2024November 18th, 2024
  • PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024
    PharmaIN to Present Promising Interim Data from Its Ongoing Phase 1 Trial of PHIN-214, an Optimized Vasopressor for Decompensated Cirrhosis, at the Liver Meeting® 2024October 16th, 2024